Protalix BioTherapeutics Price Performance
Protalix BioTherapeutics stock opened at $1.14 on Monday. Protalix BioTherapeutics has a one year low of $0.70 and a one year high of $2.00. The stock has a market capitalization of $56.72 million, a PE ratio of -2.92 and a beta of 1.78. The firm’s fifty day simple moving average is $1.12.
Protalix BioTherapeutics Company Profile
- Get a free copy of the StockNews.com research report on Protalix BioTherapeutics (PLX)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
Receive News & Ratings for Protalix BioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protalix BioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.